FDA registered labeler

Novo Nordisk A/S

Driving change to defeat serious chronic diseases

Bagsværd, DenmarkMarket cap $500B+24 listed NDC records shown

At a glance

Novo Nordisk A/S is the FDA labeler of record for Ozempic, Wegovy, Rybelsus and others. 2 of its brands bill under a HCPCS code: Ozempic (J3490), Wegovy (J3490).

Brand portfolio

Each brand opens the FDA registry filtered to that product.

Ozempic Wegovy Rybelsus Novolog Tresiba Victoza

J-code portfolio

Clinician-administered products from this labeler that carry a HCPCS code.

HCPCS codes for Novo Nordisk A/S brands
Brand	Code	Descriptor	Billable unit
Ozempic	J3490	Unclassified biologics / Semaglutide (Ozempic)	Per multi-dose pen (2 mg / 4 mg / 8 mg)
Wegovy	J3490	Unclassified biologics / Semaglutide (Wegovy)	Per single-dose pen

Registered NDC product lines

NDC 0169-7905RxRebinynGenericCoagulation factor IX recombinant, GlycoPEGylatedFormKitView details NDC 0169-4130RxJ3490OzempicGenericSemaglutideFormInjection, solutionView details NDC 0169-7010OTCNovoSeven RTGenericCoagulation Factor VIIa (Recombinant)FormKitView details NDC 0169-2084RxJ3590AlhemoGenericConcizumabFormInjection, solutionView details NDC 0169-5308RxJ3490RivflozaGenericNedosiranFormInjection, solutionView details NDC 0169-7901RxRebinynGenericCoagulation factor IX recombinant, GlycoPEGylatedFormKitView details NDC 0169-3685RxJ3590NovoLog Mix 70/30GenericInsulin aspartFormInjection, suspensionView details NDC 0169-2037RxJ3590SogroyaGenericSomapacitan-becoFormInjection, solutionView details NDC 0169-6338RxJ3590NovologGenericInsulin aspartFormInjection, solutionView details NDC 0169-7902RxRebinynGenericCoagulation factor IX recombinant, GlycoPEGylatedFormKitView details NDC 0169-3696RxJ3590NovoLog Mix 70/30GenericInsulin aspartFormInjection, suspensionView details NDC 0169-2080RxJ3590AlhemoGenericConcizumabFormInjection, solutionView details NDC 0169-6339RxJ3590NovologGenericInsulin aspartFormInjection, solutionView details NDC 0169-2081RxJ3590AlhemoGenericConcizumabFormInjection, solutionView details NDC 0169-7903RxRebinynGenericCoagulation factor IX recombinant, GlycoPEGylatedFormKitView details NDC 0169-4060RxJ3490VictozaGenericLiraglutideFormInjectionView details NDC 0169-8055OTCEsperoctGenericAntihemophilic factor (recombinant), glycopegylated-exeiFormKitView details NDC 0169-4181RxJ3490OzempicGenericSemaglutideFormInjection, solutionView details NDC 0169-7013OTCTrettenGenericCoagulation Factor XIII A-Subunit (Recombinant)FormKitView details NDC 0169-2100RxJ3590NovologGenericInsulin aspartFormInjection, solutionView details NDC 0169-8100OTCEsperoctGenericAntihemophilic factor (recombinant), glycopegylated-exeiFormKitView details NDC 0169-7020OTCNovoSeven RTGenericCoagulation Factor VIIa (Recombinant)FormKitView details NDC 0169-2101RxJ3590NovologGenericInsulin aspartFormInjection, solutionView details NDC 0169-4303RxJ3490RybelsusGenericOral semaglutideFormTabletView details

All Novo Nordisk A/S NDCs

Other manufacturers

Pfizer Inc.Eli Lilly and Company Merck & Co., Inc.Johnson & Johnson Innovative Medicine AstraZeneca Pharmaceuticals Novartis Pharmaceuticals Teva Pharmaceuticals Viatris Specialty / Mylan

All manufacturers